000 00528nam a2200109Ia 4500
008 230624s9999 xx 000 0 und d
100 _aRichard Markus et al
245 2 _aA Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
650 _aComputer science, information & general works
856 _uhttps://new.zodml.org//sites/default/files/2023-06/a_review_of_the_totality_of_evidence_supporting_the_development_of_the_first_adalimumab_biosimilar_abp_501.pdf
942 _cEBK
999 _c16109
_d16109